“Sustained disease control with aflibercept 8 mg: A turning point in the management of exudative retinal disease: Expert consenus” (2026) Ukrainian Journal of Ophthalmology , (2), pp. 71–76. doi:10.31288/Ukr.j.ophthalmol.202627176.